drugset / Trial / NCT07273656

Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead

NCT07273656

Phase 3 Not yet recruiting 59 enrolled University Hospital, Lille Almirall, SAS · collab
RandomizedSingle-groupDouble-blindTreatment

Summary

The aim of the study is to evaluate the efficacy and safety of a combined approach of cryotherapy and tirbanibulin for the treatment of actinic keratosis of the scalp and forehead, repeated every 4 months. A higher rate of complete response is expected with this combination compared to cryotherapy alone, as well as a better response with repeated treatment cycles.

Timeline

Start
2026-11-30
Primary completion
2028-11-30
Completion
2028-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tirbanibulin Small molecule Topical